4,000
Participants
Start Date
April 13, 2022
Primary Completion Date
October 1, 2025
Study Completion Date
December 1, 2026
MV-POCT Sub-study
Point of care blood testing
Main Man Van Group Sub-study (MV-Eco)
Consent for long-term follow-up of patients
MV-QualQ Sub-study
Qualitative questionnaire and interview sub-study
MV-PRS Sub-study
Patients consenting to polygenic risk score testing
MV-DNA and MV-UctDNA Sub-study
Patients consenting to collection of DNA and urine for further study.
Man Van patients
All patients seen in Man Van
MV-SSI Sub-study
Semi-structured interviews will be conducted with stakeholders involved in the running of or recruitment to the project.
MV-TPP Sub-study
Multi-stage qualitative study comprising of interviews and participatory design focus group workshops.
RECRUITING
Royal Marsden Hospital NHS Foundation Trust, London
RM Partners West London Cancer Alliance
UNKNOWN
Institute of Cancer Research, United Kingdom
OTHER
Imperial College London
OTHER
Royal Marsden NHS Foundation Trust
OTHER